Related Experiment Video
Updated: Feb 24, 2026

12:57
Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
16.6K
Omics of Prion Diseases.
1Scuola Internazionale Superiore di Studi Avanzati (SISSA), Trieste, Italy.
Progress in Molecular Biology and Translational Science
|August 26, 2017
Summary
Omics research, including genomics and proteomics, offers a powerful approach to understanding prion diseases. These high-throughput methods help identify key factors and pathways involved in neurodegeneration across human and animal models.
Area of Science:
- Neurodegenerative diseases
- Prion biology
- Genomics and proteomics
Background:
- Prion diseases are unique neurodegenerative disorders with diverse etiologies (sporadic, genetic, acquired).
- Laboratory animal models accurately recapitulate human and animal prion diseases, enabling controlled study.
- Understanding molecular mechanisms of neurodegeneration is crucial for developing therapeutic strategies.
Purpose of the Study:
- To describe the application of omics research in prion disease studies.
- To highlight the utility of comprehensive, high-throughput approaches in identifying disease factors.
- To review significant research on human and animal prion pathologies.
Main Methods:
- Utilizing omics approaches such as functional genomics, transcriptomics, and proteomics.
- Employing controlled laboratory animal models for prion disease research.
- Comprehensive and unbiased data analysis of molecular pathways.
Main Results:
- Omics approaches facilitate the identification of disease susceptibility factors.
- Dysregulated molecular pathways during prion disease onset and progression can be uncovered.
- A review of key research findings in human and animal prion diseases is presented.
Conclusions:
- Omics research provides invaluable insights into the molecular underpinnings of prion diseases.
- High-throughput studies are essential for unraveling complex neurodegenerative mechanisms.
- This chapter synthesizes current knowledge on prion disease research using omics methodologies.
Related Concept Videos
Amyloid Fibrils
12.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.1K
Amyloid Fibrils
6.8K
6.8K
Subviral Agents
642
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
642

